Clinical Trial Update: Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating whether adding oxaliplatin to gemcitabine improves outcomes in locally advanced or metastatic unresectable pancreatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Pancreatic Cancer | Phase 3 | Status: UNKNOWN